Organ Transplant Diagnostics Market - A Global and Regional Analysis: Focus on Offering, Application, Technology, Transplant Type, End User, and Country Analysis - Analysis and Forecast, 2023-2033
Global Organ Transplant Diagnostics Market: Industry Overview In 2022, the global organ transplant diagnostics market was valued at $4.03 billion and is expected to reach $11.78 billion by 2033,... もっと見る
SummaryGlobal Organ Transplant Diagnostics Market: Industry OverviewIn 2022, the global organ transplant diagnostics market was valued at $4.03 billion and is expected to reach $11.78 billion by 2033, with a CAGR of 10.45% during the forecast period 2023-2033. The key factors driving growth include a rise in the incidence of chronic diseases leading to organ failure increases in the use of transplant diagnostics, increase in the adoption of stem cell therapy and incidences of leukemia leading to an upsurge in demand for transplant diagnostics tests, advantages of developing advanced molecular and genomic technologies in the transplant diagnostics, and presence of favorable regulatory scenario including reimbursement schemes. Market Lifecycle Stage The global organ transplant diagnostics market is in the developed phase. The development of non-invasive techniques for monitoring transplant recipients using NGS and advancements in human leukocyte antigen (HLA) typing tests for an organ transplant are some of the major opportunities in the global organ transplant diagnostics market. Impact of COVID-19 The COVID-19 pandemic impacted the healthcare segment in different ways. The organ transplant segment of the industry got highly impacted by the pandemic, as the focus of hospitals and ambulatory centers shifted toward the affected patients. Moreover, as a method of prevention, surgeries got delayed, which had a significant effect on organ transplant procedures and on organ transplant diagnostics tests. Market Segmentation: Segmentation 1: by Offering • Products • Services The global organ transplant diagnostics market (by offering) is expected to be dominated by the services segment. Segmentation 2: by Transplant Type • Solid Organ Transplant • Stem Cell Transplant The global organ transplant diagnostics market (by transplant type) is expected to be dominated by the solid organ transplant segment. Segmentation 3: by Application • Diagnostics • Translational Research The global organ transplant diagnostics market (by application) is expected to be dominated by the diagnostics segment. Segmentation 4: by Technology • Molecular Technologies • Non-Molecular Technologies • Other Technologies The global organ transplant diagnostics market (by technology) is expected to be dominated by the molecular technologies segment. Segmentation 5: by End User • Hospitals and Transplant Centers • Academic and Research Institutions • Reference Laboratories • Other End Users The global organ transplant diagnostics market (by end user) is expected to be dominated by the hospitals and transplant centers segment. Segmentation 6: by Region • North America - U.S., Canada • Europe - Germany, U.K., France, Italy, Spain, Switzerland, and Rest-of-Europe • Asia-Pacific - China, Japan, India, Australia, South Korea, Singapore, and Rest-of-Asia-Pacific • Latin America - Brazil, Mexico, and Rest-of-Latin America • Rest-of-the-World The global organ transplant diagnostics market (by region) is dominated by the North America region. Recent Developments in the Global Organ Transplant Diagnostics Market • In April 2023, bioMérieux S.A. and Oxford Nanopore entered into a strategic partnership agreement to develop innovative infectious disease diagnostics, which would also lead to the development of infectious disease tests used during transplantation. • In April 2023, CareDx and Miromatrix announced an exclusive partnership to advance research using bioengineered organs for human transplantation. • In December 2022, GenDx partnered with Azure Biosystems, a leading provider of innovative bioanalytical solutions for protein and genomic research, to demonstrate the compatibility of the Azure Cielo 6 qPCR System with the GenDx KMRtype and KMRtrack kits. • In November 2022, Bio-Rad Laboratories and NuProbe USA signed a licensing agreement for digital PCR assay development. The technology would advance Bio-Rad’s portfolio. • In October 2022, Eurobio Scientific finalized the purchase of a 100% stake in Genome Diagnostics BV (GenDx) in a deal valued at $132.3 million. • In September 2022, BioMAdvanced Diagnostics announced fundraising of $1.3 million. The fundraising would allow BioMAdvanced Diagnostics to finalize the design of its first products and to start two clinical studies, one on the rejection of kidney transplants and the other on the lung. • In September 2022, BioMAdvanced Diagnostics announced the launch of Design Freeze of its IVD test for transplant kidney rejection. • In September 2022, GenDx announced that it signed a non-exclusive service agreement with Oxford Nanopore Technologies (Oxford Nanopore) to bring its new NGS-Turbo product to the transplant market for high-resolution HLA typing. Demand – Drivers and Limitations Following are the drivers for the Global Organ Transplant Diagnostics market: • Rise in the Incidence of Chronic Diseases Leading to Organ Failure Increases the Use of Transplant Diagnostics • Increase in the Adoption of Stem Cell Therapy and Incidences of Leukemia Leading to an Upsurge in Demand for Transplant Diagnostics Tests • Advantages of Developing Advanced Molecular and Genomic Technologies in the Transplant Diagnostics Tests • Presence of Favorable Regulatory Scenario Including Reimbursement Schemes The market is expected to face some limitations as well due to the following challenges: • Increased Gap in Organ Donation and Organ Transplant Demand, which Hinders the Growth of the Organ Transplant Diagnostics Market • High Cost of Investment for Transplant Diagnostics Tests How can this report add value to an organization? Offerings: The offerings segment helps the reader understand the different manufacturers and service providers available in the market for organ transplant diagnostics. Moreover, the study provides the reader with a detailed understanding of transplant types and applications. Growth/Marketing Strategy: The global organ transplant diagnostics market has witnessed major development by key players operating in the market, such as product launches, business expansions, partnerships, collaborations, mergers and acquisitions, funding activities, and regulatory and legal approvals. The favored strategy for the companies has been synergistic activities such as partnerships, collaborations, expansions, and funding activities. For instance, in April 2023, bioMérieux S.A. and Oxford Nanopore entered into a strategic partnership agreement to develop innovative infectious disease diagnostics, which will also lead to the development of infectious disease tests used during transplantation. Competitive Strategy: The key players in the global organ transplant diagnostics market analyzed and profiled in the study involve established and emerging players that offer different products and services for organ transplant diagnostics. Moreover, a detailed competitive benchmarking of the players operating in the global organ transplant diagnostics market has been done to help the reader understand the ways in which players stack against each other, presenting a clear market landscape. Moreover, comprehensive competitive strategies such as partnerships, agreements, collaborations, and mergers and acquisitions will help the reader understand the untapped revenue pockets in the market. Key Market Players and Competition Synopsis The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration. Key Companies Profiled Manufacturers • Abbott Laboratories • BAG Group GmbH • bioMérieux S.A. • Bio-Rad Laboratories, Inc. • Eurobio Scientific • F. Hoffmann-La Roche Ltd. • Illumina, Inc. • Immucor, Inc. • Omixon Inc. • QIAGEN N.V. • Thermo Fisher Scientific Inc. Service Providers • ARUP Laboratories • CareDx, Inc. • Laboratory Corporation of America Holdings • Quest Diagnostics Incorporated Table of Contents1 Product Definition1.1 Inclusion and Exclusion Criteria 2 Market Scope 2.1 Scope of Work 2.2 Key Questions Answered in the Report: 3 Research Methodology 3.1 Global Organ Transplant Diagnostics Market: Research Methodology 3.2 Data Sources 3.2.1 Primary Data Sources 3.2.2 Secondary Data Sources 3.3 Market Estimation Model 3.4 Criteria for Company Profiling 4 Global Organ Transplant Diagnostics Market: Overview 4.1 Current Market Scenario 4.1.1 For Researchers 4.1.2 For Diagnostics 4.2 Market Footprint 4.3 COVID-19 Impact on Market 4.3.1 Impact on Operations 4.3.2 COVID-19 Impact: Current Scenario of Market 4.3.3 Pre- and Post-COVID-19 Impact Assessment 4.3.3.1 Pre-COVID-19 Phase 4.3.3.2 Post-COVID-19 Phase 5 Global Organ Transplant Diagnostics Market: Industry Analysis 5.1 Overview 5.2 Legal Requirements and Regulatory Frameworks in the U.S. 5.2.1 U.S. FDA Regulation 5.2.2 CMS Regulation 5.3 Legal Requirements and Framework in Europe 5.4 Legal Requirements and Framework in Asia-Pacific 5.4.1 China 5.4.2 Japan 5.5 Reimbursement Scenario 5.6 Patent Analysis 5.6.1 Patent Filing Trend (by Country) 5.6.2 Patent Filing Trend (by Year) 6 Global Organ Transplant Diagnostics Market: Market Dynamics 6.1 Impact Analysis 6.2 Market Drivers 6.2.1 Rise in Incidence of Chronic Diseases Leading to Organ Failure Increases the Use of Transplant Diagnostics 6.2.2 Increase in Adoption of Stem Cell Therapy and Incidences of Leukemia Leading to an Upsurge in Demand for Transplant Diagnostics Tests 6.2.3 Presence of Favorable Regulatory Scenarios including Reimbursement Schemes for Some Organ Transplant Diagnostics 6.2.4 Advantages of Developing Advanced Molecular and Genomic Technologies in Transplant Diagnostics Tests 6.3 Market Restraints 6.3.1 Increased Gap in Organ Donation and Organ Transplant Demand Hinders the Growth of Organ Transplant Diagnostics Market 6.3.2 High Cost of Investment for Transplant Diagnostics Tests Acts as a Barrier to Growth of the Market 6.4 Market Opportunities 6.4.1 Development of Non-Invasive Techniques for Monitoring Transplant Recipients using NGS 6.4.2 Advancements in Human Leukocyte Antigen (HLA) Typing Tests for Organ Transplant 7 Competitive Insights 7.1 Overview 7.2 Key Strategies and Development 7.2.1 Synergistic Activities 7.2.2 Product and Service Launches 7.2.3 Product Approvals 7.2.4 Acquisitions and Mergers 7.2.5 Regulatory Accreditions 7.3 Market Share Analysis 2021 vs. 2022 7.4 Growth-Share Analysis 7.4.1 By Company 8 Global Organ Transplant Diagnostics Market: (by Offering) 8.1 Overview 8.2 Products 8.2.1 Kits and Assays 8.2.2 Consumables 8.3 Services 9 Global Organ Transplant Diagnostics Market: (by Transplant Type) 9.1 Overview 9.2 Solid Organ Transplant 9.2.1 Kidney 9.2.2 Liver 9.2.3 Lung 9.2.4 Pancreas 9.2.5 Other Organs Transplant 9.3 Stem Cell Transplant 10 Global Organ Transplant Diagnostics Market: (by Application) 10.1 Overview 10.2 Diagnostics 10.2.1 Donor Testing 10.2.1.1 Pre-Transplantation Testing 10.2.1.1.1 Histocompatibility Testing 10.2.1.1.2 Blood Profiling Testing 10.2.1.1.3 Other Testing 10.2.1.2 Post-Transplantation Testing 10.2.1.2.1 Post-Infection Testing 10.2.1.2.2 Risk of Disorder Testing 10.2.1.2.3 Other Testing 10.2.2 Recipient Testing 10.2.2.1 Pre-Transplantation Testing 10.2.2.1.1 Histocompatibility Testing 10.2.2.1.2 Blood Profiling Testing 10.2.2.1.3 Other Testing 10.2.2.2 Post-Transplantation Testing 10.2.2.2.1 Post-Infection Testing 10.2.2.2.2 Risk of Disorder Testing 10.2.2.2.3 Other Testing 10.3 Translational Research 11 Global Organ Transplant Diagnostics Market: (by Technology) 11.1 Overview 11.2 Molecular Technologies 11.2.1 PCR 11.2.2 Sanger Sequencing 11.2.3 Next-Generation Sequencing (NGS) 11.2.4 Other Molecular Technologies 11.3 Non-Molecular Technologies 11.3.1 Serology 11.3.2 Flow Cytometry 11.4 Other Technologies 12 Global Organ Transplant Diagnostics Market: (by End User) 12.1 Overview 12.2 Hospitals and Transplant Centers 12.3 Academic and Research Institutions 12.4 Reference Laboratories 12.5 Other End Users 13 Region 13.1 North America 13.1.1 North America Organ Transplant Test Volume, by Transplant Type 13.1.2 Market Sizing and Forecast 13.1.2.1 North America Organ Transplant Diagnostics Market (by Country) 13.1.2.1.1 U.S. 13.1.2.1.2 Canada 13.2 Europe 13.2.1 Europe Organ Transplant Test Volume, by Transplant Type 13.2.2 Market Sizing and Forecast 13.2.2.1 Europe Organ Transplant Diagnostics Market (by Country) 13.2.2.1.1 France 13.2.2.1.2 Spain 13.2.2.1.3 U.K. 13.2.2.1.4 Italy 13.2.2.1.5 Germany 13.2.2.1.6 Switzerland 13.2.2.1.7 Rest-of-Europe 13.3 Asia-Pacific 13.3.1 Asia-Pacific Organ Transplant Test Volume, by Transplant Type 13.3.2 Market Sizing and Forecast 13.3.2.1 Asia-Pacific Organ Transplant Diagnostics Market (by Country) 13.3.2.1.1 China 13.3.2.1.2 India 13.3.2.1.3 South Korea 13.3.2.1.4 Japan 13.3.2.1.5 Australia 13.3.2.1.6 Singapore 13.3.2.1.7 Rest-of-Asia-Pacific 13.4 Latin America 13.4.1 Latin America Organ Transplant Test Volume, by Transplant Type 13.4.2 Market Sizing and Forecast 13.4.2.1 Latin America Organ Transplant Diagnostics Market (by Country) 13.4.2.1.1 Brazil 13.4.2.1.2 Mexico 13.4.2.1.3 Rest-of-Latin America 13.5 Rest-of-the-World 13.5.1 Rest-of-the-World Organ Transplant Test Volume, by Transplant Type 13.5.2 Market Sizing and Forecast 14 Company Profiles 14.1 Overview 14.2 Manufacturers 14.2.1 Abbott Laboratories 14.2.1.1 Company Overview 14.2.1.2 Role of Abbott Laboratories in the Organ Transplant Diagnostics Market 14.2.1.3 Product Portfolio 14.2.1.4 Financials 14.2.1.5 Analyst Perception 14.2.2 BAG Group GmbH 14.2.2.1 Company Overview 14.2.2.2 Role of BAG Group GmbH in the Organ Transplant Diagnostics Market 14.2.2.3 Product Portfolio 14.2.2.4 Analyst Perception 14.2.3 bioMérieux S.A. 14.2.3.1 Company Overview 14.2.3.2 Role of bioMérieux S.A. in the Organ Transplant Diagnostics Market 14.2.3.3 Product Portfolio 14.2.3.4 Financials 14.2.3.5 Recent Developments 14.2.3.6 Analyst Perception 14.2.4 Bio-Rad Laboratories, Inc. 14.2.4.1 Company Overview 14.2.4.2 Role of Bio-Rad Laboratories, Inc. in the Organ Transplant Diagnostics Market 14.2.4.3 Product Portfolio 14.2.4.4 Financials 14.2.4.5 Recent Developments 14.2.4.6 Analyst Perception 14.2.5 Eurobio Scientific (Genome Diagnostics B.V.) 14.2.5.1 Company Overview 14.2.5.2 Role of Eurobio Scientific (Genome Diagnostics B.V.) in the Organ Transplant Diagnostics Market 14.2.5.3 Product Portfolio 14.2.5.4 Analyst Perception 14.2.6 F. Hoffmann-La Roche Ltd. 14.2.6.1 Company Overview 14.2.6.2 Role of F. Hoffmann-La Roche Ltd. in the Organ Transplant Diagnostics Market 14.2.6.3 Product Portfolio 14.2.6.4 Financials 14.2.6.5 Recent Developments 14.2.6.6 Analyst Perception 14.2.7 Illumina, Inc. 14.2.7.1 Company Overview 14.2.7.2 Role of Illumina, Inc. in the Organ Transplant Diagnostics Market 14.2.7.3 Product Portfolio 14.2.7.4 Financials 14.2.7.5 Analyst Perception 14.2.8 Immucor, Inc. 14.2.8.1 Company Overview 14.2.8.2 Role of Immucor, Inc. in the Organ Transplant Diagnostics Market 14.2.8.3 Product Portfolio 14.2.8.4 Analyst Perception 14.2.9 Omixon Inc. 14.2.9.1 Company Overview 14.2.9.2 Role of Omixon Inc. in the Organ Transplant Diagnostics Market 14.2.9.3 Product Portfolio 14.2.9.4 Analyst Perception 14.2.10 QIAGEN N.V. 14.2.10.1 Company Overview 14.2.10.2 Role of QIAGEN N.V. in the Organ Transplant Diagnostics Market 14.2.10.3 Product Portfolio 14.2.10.4 Financials 14.2.10.5 Recent Developments 14.2.10.6 Analyst Perception 14.2.11 Thermo Fisher Scientific Inc. 14.2.11.1 Company Overview 14.2.11.2 Role of Thermo Fisher Scientific Inc. in the Organ Transplant Diagnostics Market 14.2.11.3 Product Portfolio 14.2.11.4 Financials 14.2.11.5 Recent Developments 14.2.11.6 Analyst Perception 14.3 Service Providers 14.3.1 ARUP Laboratories 14.3.1.1 Company Overview 14.3.1.2 Role of ARUP Laboratories in the Organ Transplant Diagnostics Market 14.3.1.3 Product Portfolio 14.3.1.4 Analyst Perception 14.3.2 CareDx, Inc. 14.3.2.1 Company Overview 14.3.2.2 Role of CareDx, Inc. in the Organ Transplant Diagnostics Market 14.3.2.3 Product Portfolio 14.3.2.4 Financials 14.3.2.5 Recent Developments 14.3.2.6 Analyst Perception 14.3.3 Laboratory Corporation of America Holdings 14.3.3.1 Company Overview 14.3.3.2 Role of Laboratory Corporation of America Holdings in the Organ Transplant Diagnostics Market 14.3.3.3 Product Portfolio 14.3.3.4 Financials 14.3.3.5 Analyst Perception 14.3.4 Quest Diagnostics Incorporated 14.3.4.1 Company Overview 14.3.4.2 Role of Quest Diagnostics Incorporated in the Organ Transplant Diagnostics Market 14.3.4.3 Product Portfolio 14.3.4.4 Financials 14.3.4.5 Analyst Perception List of Figures Figure 1: Global Organ Transplant Diagnostics Market, $Billion, 2022-2033 Figure 2: Global Organ Transplant Diagnostics Market, Impact Analysis Figure 3: Global Organ Transplant Diagnostics Market (by Offering), Share (%), 2022 and 2033 Figure 4: Global Organ Transplant Diagnostics Market (by Transplant Type), Share (%), 2022 and 2033 Figure 5: Global Organ Transplant Diagnostics Market (by Application), Share (%), 2022 and 2033 Figure 6: Global Organ Transplant Diagnostics Market (by Technology), Share (%), 2022 and 2033 Figure 7: Global Organ Transplant Diagnostics Market (by End User), Share (%), 2022 and 2033 Figure 8: Global Organ Transplant Diagnostics Market (by Region), $Billion, 2022 and 2033 Figure 9: Global Organ Transplant Diagnostics Market Segmentation Figure 10: Global Organ Transplant Diagnostics Market: Research Methodology Figure 11: Primary Research Methodology Figure 12: Bottom-Up Approach (Segment-Wise Analysis) Figure 13: Top-Down Approach (Segment-Wise Analysis) Figure 14: Global Organ Transplant Diagnostics Market, $Billion, 2022-2033 Figure 15: Global Organ Transplant Diagnostics Market, Patent Analysis (by Country), January 2018-December 2022 Figure 16: Global Organ Transplant Diagnostics Market, Patent Analysis (by Year), January 2018-December 2022 Figure 17: Global Organ Transplant Diagnostics Market, Impact Analysis Figure 18: New Liver Cirrhosis and Other Chronic Liver Diseases Cases, Thousand, 2017 and 2021 Figure 19: Global Number of Solid Organ Transplants, 2017-2021 Figure 20: Applications of Stem Cell Therapy Figure 21: Number of Transplants Performed and Patients on the Waiting List (by Organ), 2022 Figure 22: Global Organ Transplant Diagnostics Market, Total Number of Key Developments, January 2018-April 2023 Figure 23: Synergistic Activities, January 2018-April 2023 Figure 24: Product and Service Launches, January 2018-April 2023 Figure 25: Product Approvals, January 2018-April 2023 Figure 26: Acquisitions and Mergers, January 2018-April 2023 Figure 27: Regulatory Accreditions, January 2018-April 2023 Figure 28: Global Organ Transplant Diagnostics Market, Market Share Analysis, %, 2021 and 2022 Figure 29: Global Organ Transplant Diagnostics Market, Growth-Share Matrix (by Company), 2022 Figure 30: Global Organ Transplant Diagnostics Market (by Offering) Figure 31: Global Organ Transplant Diagnostics Market (Products), $Billion, 2022-2033 Figure 32: Global Organ Transplant Diagnostics Market (Kits and Assays), $Million, 2022-2033 Figure 33: Global Organ Transplant Diagnostics Market (Consumables), $Million, 2022-2033 Figure 34: Global Organ Transplant Diagnostics Market (Services), $Billion, 2022-2033 Figure 35: Global Organ Transplant Diagnostics Market (by Transplant Type) Figure 36: Global Organ Transplant Diagnostics Market (Solid Organ Transplant), $Billion, 2022-2033 Figure 37: Global Organ Transplant Diagnostics Market (Kidney), $Billion, 2022-2033 Figure 38: Global Organ Transplant Diagnostics Market (Liver), $Million, 2022-2033 Figure 39: Global Organ Transplant Diagnostics Market (Lung), $Million, 2022-2033 Figure 40: Global Organ Transplant Diagnostics Market (Pancreas), $Million, 2022-2033 Figure 41: Global Organ Transplant Diagnostics Market (Other Organs Transplant), $Million, 2022-2033 Figure 42: Global Organ Transplant Diagnostics Market (Stem Cell Transplant), $Billion, 2022-2033 Figure 43: Global Organ Transplant Diagnostics Market (by Application) Figure 44: Global Organ Transplant Diagnostics Market (Diagnostics), $Billion, 2022-2033 Figure 45: Global Organ Transplant Diagnostics Market (Donor Testing), $Billion, 2022-2033 Figure 46: Global Organ Transplant Diagnostics Market (Pre-Transplantation Testing), $Million, 2022-2033 Figure 47: Global Organ Transplant Diagnostics Market (Histocompatibility Testing), $Million, 2022-2033 Figure 48: Global Organ Transplant Diagnostics Market (Blood Profiling Testing), $Million, 2022-2033 Figure 49: Global Organ Transplant Diagnostics Market (Other Testing), $Million, 2022-2033 Figure 50: Global Organ Transplant Diagnostics Market (Post-Transplantation Testing), $Million, 2022-2033 Figure 51: Global Organ Transplant Diagnostics Market (Post-Infection Testing), $Million, 2022-2033 Figure 52: Global Organ Transplant Diagnostics Market (Risk of Disorder Testing), $Million, 2022-2033 Figure 53: Global Organ Transplant Diagnostics Market (Other Testing), $Million, 2022-2033 Figure 54: Global Organ Transplant Diagnostics Market (Recipient Testing), $Billion, 2022-2033 Figure 55: Global Organ Transplant Diagnostics Market (Pre-Transplantation Testing), $Million, 2022-2033 Figure 56: Global Organ Transplant Diagnostics Market (Histocompatibility Testing), $Million, 2022-2033 Figure 57: Global Organ Transplant Diagnostics Market (Blood Profiling Testing), $Million, 2022-2033 Figure 58: Global Organ Transplant Diagnostics Market (Other Testing), $Million, 2022-2033 Figure 59: Global Organ Transplant Diagnostics Market (Post-Transplantation Testing), $Billion, 2022-2033 Figure 60: Global Organ Transplant Diagnostics Market (Post-Infection Testing), $Million, 2022-2033 Figure 61: Global Organ Transplant Diagnostics Market (Risk of Disorder Testing), $Million, 2022-2033 Figure 62: Global Organ Transplant Diagnostics Market (Other Testing), $Million, 2022-2033 Figure 63: Global Organ Transplant Diagnostics Market (Translational Research), $Million, 2022-2033 Figure 64: Global Organ Transplant Diagnostics Market (by Technology) Figure 65: Global Organ Transplant Diagnostics Market (Molecular Technologies), $Billion, 2022-2033 Figure 66: Global Organ Transplant Diagnostics Market (PCR), $Million, 2022-2033 Figure 67: Global Organ Transplant Diagnostics Market (Sanger Sequencing), $Million, 2022-2033 Figure 68: Global Organ Transplant Diagnostics Market (Next-Generation Sequencing), $Million, 2022-2033 Figure 69: Global Organ Transplant Diagnostics Market (Other Molecular Technologies), $Million, 2022-2033 Figure 70: Global Organ Transplant Diagnostics Market (Non-Molecular Technologies), $Billion, 2022-2033 Figure 71: Global Organ Transplant Diagnostics Market (Serology), $Billion, 2022-2033 Figure 72: Global Organ Transplant Diagnostics Market (Flow Cytometry), $Million, 2022-2033 Figure 73: Global Organ Transplant Diagnostics Market (Other Technologies), $Million, 2022-2033 Figure 74: Global Organ Transplant Diagnostics Market (by End User) Figure 75: Global Organ Transplant Diagnostics Market (Hospitals and Transplant Centers), $Billion, 2022-2033 Figure 76: Global Organ Transplant Diagnostics Market (Academic and Research Institutions), $Billion, 2022-2033 Figure 77: Global Organ Transplant Diagnostics Market (Reference Laboratories), $Million, 2022-2033 Figure 78: Global Organ Transplant Diagnostics Market (Other End Users), $Million, 2022-2033 Figure 79: Global Organ Transplant Diagnostics Market Share and CAGR (by Region), 2022 and 2023-2033 Figure 80: North America Organ Transplant Diagnostics Market, $Billion, 2022-2033 Figure 81: North America Organ Transplant Diagnostics Market (by Country), Share (%), 2023 and 2033 Figure 82: U.S. Organ Transplant Diagnostics Market, $Billion, 2022-2033 Figure 83: Canada Organ Transplant Diagnostics Market, $Million, 2022-2033 Figure 84: Europe Organ Transplant Diagnostics Market, $Billion, 2022-2033 Figure 85: Europe Organ Transplant Diagnostics Market (by Country), Share (%), 2022 and 2033 Figure 86: France Organ Transplant Diagnostics Market, $Million, 2022-2033 Figure 87: Spain Organ Transplant Diagnostics Market, $Million, 2022-2033 Figure 88: U.K. Organ Transplant Diagnostics Market, $Million, 2022-2033 Figure 89: Italy Organ Transplant Diagnostics Market, $Million, 2022-2033 Figure 90: Germany Organ Transplant Diagnostics Market, $Million, 2022-2033 Figure 91: Switzerland Organ Transplant Diagnostics Market, $Million, 2022-2033 Figure 92: Rest-of-Europe Organ Transplant Diagnostics Market, $Million, 2022-2033 Figure 93: Asia-Pacific Organ Transplant Diagnostics Market, $Billion, 2022-2033 Figure 94: Asia-Pacific Organ Transplant Diagnostics Market (by Country), Share (%), 2022 and 2033 Figure 95: China Organ Transplant Diagnostics Market, $Million, 2022-2033 Figure 96: India Organ Transplant Diagnostics Market, $Million, 2022-2033 Figure 97: South Korea Organ Transplant Diagnostics Market, $Million, 2022-2033 Figure 98: Japan Organ Transplant Diagnostics Market, $Million, 2022-2033 Figure 99: Australia Organ Transplant Diagnostics Market, $Million, 2022-2033 Figure 100: Singapore Organ Transplant Diagnostics Market, $Million, 2022-2033 Figure 101: Rest-of-Asia-Pacific Organ Transplant Diagnostics Market, $Million, 2022-2033 Figure 102: Latin America Organ Transplant Diagnostics Market, $Million, 2022-2033 Figure 103: Latin America Organ Transplant Diagnostics Market (by Country), Share (%), 2022 and 2033 Figure 104: Brazil Organ Transplant Diagnostics Market, $Million, 2022-2033 Figure 105: Mexico Organ Transplant Diagnostics Market, $Million, 2022-2033 Figure 106: Rest-of-Latin America Organ Transplant Diagnostics Market, $Million, 2022-2033 Figure 107: Rest-of-the-World Organ Transplant Diagnostics Market, $Million, 2022-2033 Figure 108: Total Number of Companies Profiled Figure 109: Global Organ Transplant Diagnostics Market Overview, Key Companies Figure 110: Abbott Laboratories: Product Portfolio Figure 111: Abbott Laboratories: Overall Financials, $Billion, 2020-2022 Figure 112: Abbott Laboratories: Net Revenue (by Business Segment), $Billion, 2020-2022 Figure 113: Abbott Laboratories: Net Revenue (by Region), $Billion, 2020-2022 Figure 114: Abbott Laboratories: R&D Expenditure, $Billion, 2020-2022 Figure 115: BAG Group GmbH: Overall Product Portfolio Figure 116: bioMérieux S.A.: Overall Product Portfolio Figure 117: bioMérieux S.A.: Overall Financials, $Million, 2019-2021 Figure 118: bioMérieux S.A.: Net Revenue (by Region), $Million, 2019-2021 Figure 119: bioMérieux S.A.: R&D Expenditure, $Million, 2019-2021 Figure 120: Bio-Rad Laboratories, Inc.: Product Portfolio Figure 121: Bio-Rad Laboratories, Inc.: Overall Financials, $Billion, 2020-2022 Figure 122: Bio-Rad Laboratories, Inc.: Net Revenue (by Business Segment), $Million, 2020-2022 Figure 123: Bio-Rad Laboratories, Inc.: Net Revenue (by Region), $Million, 2020-2022 Figure 124: Bio-Rad Laboratories, Inc.: R&D Expenditure, $Million, 2020-2022 Figure 125: Eurobio Scientific (Genome Diagnostics B.V.): Overall Product Portfolio Figure 126: F. Hoffmann-La Roche Ltd.: Overall Product Portfolio Figure 127: F. Hoffmann-La Roche Ltd.: Overall Financials, $Billion, 2020-2022 Figure 128: F. Hoffmann-La Roche Ltd.: Net Revenue (by Business Segment), $Billion, 2020-2022 Figure 129: F. Hoffmann-La Roche Ltd.: Diagnostics Revenue (by Region), $Billion, 2020-2022 Figure 130: F. Hoffmann-La Roche Ltd.: R&D Expenditure, $Billion, 2020-2022 Figure 131: Illumina, Inc.: Overall Product Portfolio Figure 132: Illumina, Inc.: Overall Financials, $Million, 2020-2022 Figure 133: Illumina, Inc.: Net Revenue (by Business Segment), $Million, 2020-2022 Figure 134: Illumina, Inc.: Net Revenue (by Region), $Million, 2020-2022 Figure 135: Illumina, Inc.: R&D Expenditure, $Million, 2020-2022 Figure 136: Immucor, Inc.: Product Portfolio Figure 137: Omixon Inc.: Overall Product Portfolio Figure 138: QIAGEN N.V.: Product Portfolio Figure 139: QIAGEN N.V.: Overall Financials, $Million, 2019-2021 Figure 140: QIAGEN N.V.: Net Revenue (by Business Segment), $Million, 2019-2021 Figure 141: QIAGEN N.V.: Net Revenue (by Region), $Million, 2019-2021 Figure 142: QIAGEN N.V.: R&D Expenditure, $Million, 2019-2021 Figure 143: Thermo Fisher Scientific Inc.: Product Portfolio Figure 144: Thermo Fisher Scientific Inc.: Overall Financials, $Billion, 2020-2022 Figure 145: Thermo Fisher Scientific Inc.: Net Revenue (by Business Segment), $Billion, 2020-2022 Figure 146: Thermo Fisher Scientific Inc.: Net Revenue (by Region), $Billion,2020-2022 Figure 147: Thermo Fisher Scientific Inc.: R&D Expenditure, $Billion, 2020-2022 Figure 148: ARUP Laboratories: Overall Product Portfolio Figure 149: CareDx, Inc.: Overall Product Portfolio Figure 150: CareDx, Inc.: Overall Financials, $Million, 2020-2022 Figure 151: CareDx, Inc.: Net Revenue (by Business Segment), $Million, 2020-2022 Figure 152: CareDx, Inc.: Net Revenue (by Region), $Million, 2020-2022 Figure 153: CareDx, Inc.: R&D Expenditure, $Million, 2020-2022 Figure 154: Laboratory Corporation of America Holdings: Overall Product Portfolio Figure 155: Laboratory Corporation of America Holdings: Overall Financials, $Billion, 2020-2022 Figure 156: Laboratory Corporation of America Holdings: Net Revenue (by Business Segment), $Billion, 2020-2022 Figure 157: Quest Diagnostics Incorporated: Product Portfolio Figure 158: Quest Diagnostics Incorporated: Overall Financials, $Billion, 2020-2022 Figure 159: Quest Diagnostics Incorporated: Net Revenue (by Business Segment), $Billion, 2020-2022 List of Tables Table 1: Key Questions Answered in the Report Table 2: Key Coverage Providers for Organ Transplant Diagnostics Tests Table 3: North America Organ Transplant Diagnostics Market, Impact Analysis Table 4: North America Organ Transplant Test Volume, by Transplant Type, 2021 Table 5: Europe Organ Transplant Diagnostics Market, Impact Analysis Table 6: Europe Organ Transplant Test Volume, by Transplant Type, 2021 Table 7: Asia-Pacific Organ Transplant Diagnostics Market, Impact Analysis Table 8: Asia-Pacific Organ Transplant Test Volume, by Transplant Type, 2021 Table 9: Latin America Organ Transplant Diagnostics Market, Impact Analysis Table 10: Latin America Organ Transplant Test Volume, by Transplant Type, 2021 Table 11: Rest-of-the-World Organ Transplant Diagnostics Market, Impact Analysis Table 12: Rest-of-the-World Organ Transplant Test Volume, by Transplant Type, 2021 Press Release
The global organ transplant diagnostics market is estimated to reach $11.78 billion in 2033, reveals the premium market intelligence study by BIS Research. The study also highlights that the market is set to witness a CAGR of 10.45% during the forecast period 2023-2033.
The global organ transplant diagnostics market is anticipated to be influenced by various factors during the forecast period 2023-2033. The key factors driving growth include a rise in the incidence of chronic diseases leading to organ failure increases the use of transplant diagnostics, increase in the adoption of stem cell therapy and incidences of leukemia leading to an upsurge in demand for transplant diagnostics tests, advantages of developing advanced molecular and genomic technologies in the transplant diagnostics, and presence of favorable regulatory scenario including reimbursement schemes. USP of the Report • Impact of COVID-19 on organ transplant diagnostics, including the detailed analysis of pre-COVID-19 and COVID-19 scenarios, along with the future impact of the COVID-19 pandemic on the market • Extensive product benchmarking of the top players (including established and emerging players) to offer a holistic view of the organ transplant diagnostics market product landscape • Key trends and opportunities of the market • Patent analysis • Regulatory scenario in different countries • Different distribution and marketing strategies adopted by key players operating in the market • Market share analysis based on product portfolios, recent developments, and regional spread of the key players • Market dynamics, including drivers and restraints • Region and country-level analysis, including market dynamics and market size and forecast • Reimbursement scenario for organ transplant diagnostics • Value and supply chain analysis • Global ecosystem glimpse for organ transplant diagnostics market Analyst Perspective To emphasize the potential of the global organ transplant diagnostics market, Swati Sood, Principal Analyst – BIS Research, states, “With a rise in the incidence of chronic diseases leading to organ failure and upsurge in adoption of stem cell therapy, the global organ transplant diagnostics market is expected to witness significant growth.” Key Companies Operating in The Market The key players in the global organ transplant diagnostics market analyzed and profiled in the study involve established and emerging players that offer different products and services for organ transplant diagnostics. Moreover, a detailed competitive benchmarking of the players operating in the global organ transplant diagnostics market has been done to help the reader understand the ways in which players stack against each other, presenting a clear market landscape. Moreover, comprehensive competitive strategies such as partnerships, agreements, collaborations, and mergers and acquisitions will help the reader understand the untapped revenue pockets in the market. The key players profiled in the report include Abbott Laboratories, BAG Group GmbH, bioMérieux S.A., Bio-Rad Laboratories, Inc., Eurobio Scientific, F. Hoffmann-La Roche Ltd., Illumina, Inc., Immucor, Inc., Omixon Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., ARUP Laboratories, CareDx, Inc., Laboratory Corporation of America Holdings, and Quest Diagnostics Incorporated. Key Questions Answered in the Report • What are the major market drivers, challenges, and opportunities for the global organ transplant diagnostics market? • How is each offering type of the global organ transplant diagnostics market expected to grow during the forecast period 2023-2033? • How are different applications of the global organ transplant diagnostics market expected to grow during the forecast period 2023-2033? • What is the patent filing trend for the global organ transplant diagnostics market? • What is the growth-share analysis by the company? • How is each transplant type of the global organ transplant diagnostics market expected to grow during the forecast period 2023-2033? • What is the market share analysis for 2021 and 2022? • What is the growth potential of the global organ transplant diagnostics market in North America, Europe, Asia-Pacific, Latin America, and Rest-of the-world? • What is the regulatory scenario in different regions for organ transplant diagnostics? • How has the COVID-19 pandemic impacted the global organ transplant diagnostics market? • How is the technology segment of the global organ transplant diagnostics market expected to grow during the forecast period 2023-2033?
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(診断薬)の最新刊レポート
BIS Research 社の最新刊レポート本レポートと同じKEY WORD(end user)の最新刊レポート
よくあるご質問BIS Research社はどのような調査会社ですか?多数のアナリストチームと大規模な業界専門家のネットワークを擁するBISリサーチは、市場に影響を与える革新的な技術に関して、高度なマーケットインテリジェンスを提供しています。特に、新興テクノロジーに関す... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/08 10:26 154.13 円 166.76 円 202.76 円 |